28
Brain Tumors in Pediatrics Resident Education Lecture Series

Brain Tumors in Pediatrics Resident Education Lecture Series

Embed Size (px)

Citation preview

Brain Tumors in Pediatrics

Resident Education Lecture Series

Brain Tumors - Background

20-30% of cancers in children 2500-3000 new diagnoses/year 2nd most common neoplasm Most occur before age 10 years Male/Female = 1.3/1.0 60-70% 5 year survival

Relative Incidence of Brain Tumors in Children

Table 25-1. Approximate incidence of common CNS tumors in children.

Pizzo & Poplack

Location – Supra vs. Infra

Supratentorial 25-40% Astrocytoma, low grade 8-20% Astrocytoma, high grade 6-12% Ependymoma 2-5% Mixed glioma 1-5% Ganglioglioma 1-5% Oligodendroglioma 1-2% PNET 1-2% Choroid plexus tumor 1-2% Meningioma 1-2% Germ Cell Tumors 1-2% Other 1-3%

Location – Supra vs. Infra

Infratentorial 45-60%

Medulloblastoma (PNET) 20-25% Astrocytoma, low grade 12-18% Ependymoma 4-8% Brain stem glioma, high grade 3-9% Brain stem glioma, low grade 3-6% Other 2-5%

Brain Tumors - Signs/Symptoms

Increased intracranial pressure - symptoms Headache (am) Nausea/vomiting (am) Double vision Head tilt Decreased alertness Lethargy/irritability Poor feeding, FTT Endocrine dysfunction Unexplained behavior changes

- affect, motivation, energy level

Brain Tumors – Signs/Symptoms

Increased ICP – Signs Papilledema, optic atrophy Loss of vision OFC (head circumference) increased Bulging fontanelles, spreading sutures “Setting sun” sign (Parinaud syndrome) Increased blood pressure, low pulse

herniation?

Posterior Fossa & Brainstem Tumors - Clinical Features

Posterior Fossa primaryAtaxiaTremorsDysarthriaStiff neckPapilledema

Brainstem primaryExtremity weaknessCranial nerve signs

– double vision

– facial weakness

– swallowing dysfunction

Hemispheric Tumors – Clinical Features

Hemiparesis Hemianopsia Aphasia Seizures

Treatment

Tumor Type Surgery XRT Chemo

Medulloblastoma +++ CrSp +++

Low grade astro +++ focal ----

cerebellar +++ ???? ----

optic glioma NO ???? ????

High grade astro/GBM +++ +++ ?

Brain stem glioma (exophytic) focal ?

Ependymoma +++ focal ----

Germ cell tumor ? bx +++ +++

Treatment - Surgery

In general, needed for diagnosis

- exceptions: GCT, BSG Ideal is gross total resection

Balance prognosis vs. morbidity Debulking, shunts, reservoirs

- for symptom/ICP reduction, therapy

Treatment – Radiation Therapy

Potential for use in all brain tumors– exceptions: choroid plexus tumors

Neuro-axis prophylaxis (cranio-spinal rx)– if tumor disseminates via CSF

Concerns for long term effects– neuro-cognitive– hearing– secondary cancers– endocrine– skeletal growth

Therapy - Chemotherapy

Adjunct therapy in most cases– particularly in GCT, medulloblastoma

Of interest in young children – (avoid or prolong XRT)

Blood brain barrier may be limiting– Newer studies suggest this may not be so

– Local delivery via pumps/reservoir/IT

Medulloblastoma/PNET

Similar histology, different tumor names based on location. – Therapies vary

Medulloblastoma - posterior fossa PNET - supratentorial Pineoblastoma - pineal region median age 5 years M:F = 2:1 propensity to disseminate

– 1/3 with metastatic disease at diagnosis

Medulloblastoma Prognostic Factors

Age - Younger tend to do worse Extent of resection Non-posterior fossa tumors Non-localized disease Standard risk 70-80% 5 yr survival

High risk 50%

what are risk groups?

Medulloblastoma

CSF dissemination – check for leptomeningeal spread – brain/spine MRI, LP

Can spread to lung, liver, BM, bone, LN’s – rare

Difference between supratentorial PNET (sPNET), medulloblastoma, and pineoblostoma?

Ependymoma

10% of childhood brain tumorsMedian age = 3-4 yrs2/3 of primary in posterior fossaMay have leptomeningeal spread -

MRI of brain/spine, CSFPrognostic factors:

– Extent of resection!!!– Age: some reports of better survival if > 5-7

years at diagnosis– Histology

Ependymoma - continued

Extent of resection most important– Near to gross total resection 50-75%– Less than NTR 0-30%

Radiation therapy helps survival– Reduces local recurrence

Chemotherapy has not shown efficacyRecurrence is rarely fixable

Brain Stem Gliomas

Diffuse intrinsic pontine gliomas– median survival = 6-9 months– death within 2 years > 90%– Radiation - transient clinical improvement

Low grade gliomas– tectal, exophytic, extra-medullary– highly enhancing on MRI– more indolent

Low Grade Astrocytoma/Glioma

30-35% of CNS tumors– 40-50% supratentorial, virtually anywhere

M:F = 2:1Association with NF-1

– more indolent courseGTR >90% 5 year survivalRX

– Radiation– Chemo if symptomatic, progressive, or recurrent

Brain Tumors in < 3 year olds

60-70% supratentorialXRT has significant neuro-cognitive effectsGoal of therapies:

– Delay XRT to at least 3 yrs old with chemotherapy most relapse prior to XRT

Current study– Short course (16 wks) chemo– 2nd look surgery– Focal (conformal) XRT– Maintenance chemotherapy

Complications From Tumor/Therapy

Neurological deficits– limb paresis

• Rehab/PT/OT, support

– swallowing/speech dysfunction• ENT, Speech therapy• Nutrition issues

– neuro-cognitive deficits• School/education issues• Social interaction issues

– endocrine dysfunction– end-organ damage

• kidney, liver, hearing, neuropathy

From ABP Certifying Exam Content Outline

Recognize the signs and symptoms of craniopharyngioma

Recognize the clinical manifestations of brain tumor

Recognize the physical characteristics of a headache due to increased intracranial pressure

Differentiate the clinical manifestations of spinal cord compression (eg, from a tumor) from those of other myelopathies, and evaluate appropriately

Credits

Sachin Jogal MD